Neuraxis Inc (NRXS)

$6.86 +0.38 (5.86%)
Market Cap 73.08M
Revenue (ttm) 2.69M
Net Income (ttm) -8.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -306.32%
Debt to Equity Ratio 0.00
Volume 511,200
Avg Vol 120,144
Day's Range N/A - N/A
Shares Out 10.65M
Stochastic %K 70%
Beta 2.49
Analysts Strong Sell
Price Target $8.00

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly kno...

Industry: Biotechnology
Sector: Healthcare
Phone: 812 689 0791
Address:
11611 North Meridian St, Suite 330, Carmel, United States
stockinvestor102
stockinvestor102 Mar. 12 at 5:09 PM
Bought shares of $NRXS
1 · Reply
Andyc545
Andyc545 Mar. 11 at 2:48 AM
$NRXS ATH!! and this board is quiet...
1 · Reply
S144
S144 Mar. 10 at 6:17 PM
$NRXS +11% today ! @alexpitti
1 · Reply
trading_momentum_x
trading_momentum_x Mar. 10 at 10:59 AM
$NRXS back on watch after its cup and handle breakout now potentially flagging on smaller timeframes. Has decent support near 5.55 with multiple touches and good buy volume Todays hammer candle suggest buyers are still interested here. Would take entry on recapture of 5dema for a change of direction.
0 · Reply
wallstpirate
wallstpirate Mar. 2 at 5:11 PM
$NRXS Amazing video https://microcapclub.com/neuraxis-nrxs-growth-stage-medtech/
0 · Reply
S144
S144 Mar. 2 at 3:37 PM
$NRXS NeurAxis (NRXS): Growth-Stage Medtech: https://microcapclub.com/neuraxis-nrxs-growth-stage-medtech Interview with CEO: https://www.youtube.com/watch?v=HTd_XbwODF4 @alexpitti
1 · Reply
Tennis_4567
Tennis_4567 Mar. 2 at 1:11 PM
$NRXS https://youtu.be/HTd_XbwODF4?si=-niYpsR07tbu0m2k
0 · Reply
S144
S144 Mar. 2 at 7:27 AM
$NRXS Subscribe to Microcap Opportunities at substack. They have the best info about the stock. The latest article: Our Flagship Stock NeurAxis (NRXS) is Sailing Fast... and Just Getting Started! https://microcapopportunities.substack.com/p/our-flagship-stock-neuraxis-nrxs
0 · Reply
trading_momentum_x
trading_momentum_x Mar. 1 at 3:35 AM
$NRXS cup and handle still fully playing out and now in a former supply zone near 6$ Potential is here is 6.70 area and then on to all time high levels. Tons of buy volume forming in current range and very bullish as long as price holds 5.66 area
0 · Reply
S144
S144 Feb. 26 at 7:46 PM
$NRXS $5.7 ! It will be $6 very soon.
0 · Reply
Latest News on NRXS
NeurAxis, Inc. (NRXS) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 2:51 PM EST - 4 months ago

NeurAxis, Inc. (NRXS) Q3 2025 Earnings Call Transcript

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

Nov 11, 2025, 7:00 AM EST - 4 months ago

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 12:29 PM EDT - 7 months ago

NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

Jun 17, 2025, 8:00 AM EDT - 9 months ago

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

May 22, 2025, 1:03 PM EDT - 10 months ago

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

NeurAxis Announces $5.0 Million Registered Direct Offering

May 21, 2025, 7:00 AM EDT - 10 months ago

NeurAxis Announces $5.0 Million Registered Direct Offering

NeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 1:58 PM EDT - 10 months ago

NeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

May 12, 2025, 8:15 AM EDT - 10 months ago

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

May 5, 2025, 9:00 AM EDT - 11 months ago

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 4:18 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Mar 20, 2025, 8:15 AM EDT - 1 year ago

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

Mar 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

Jan 21, 2025, 1:45 PM EST - 1 year ago

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Jan 21, 2025, 9:00 AM EST - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

NeurAxis Inc. Issues Letter to Shareholders

Jan 13, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. Issues Letter to Shareholders

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Jan 6, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 2:04 PM EST - 1 year ago

NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Nov 12, 2024, 8:10 AM EST - 1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Oct 22, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Sep 19, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 27, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 13, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 5:44 AM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript

NeurAxis Reports Second Quarter 2024 Financial Results

Aug 9, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports Second Quarter 2024 Financial Results

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

Jun 7, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript

May 22, 2024, 1:34 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript

NeurAxis Reports First Quarter 2024 Financial Results

May 22, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports First Quarter 2024 Financial Results

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 21, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

May 15, 2024, 4:30 PM EDT - 1 year ago

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

NeurAxis Announces New Medical Policy Coverage in North Dakota

Apr 23, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces New Medical Policy Coverage in North Dakota

NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript

Apr 9, 2024, 6:45 PM EDT - 2 years ago

NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Apr 9, 2024, 4:05 PM EDT - 2 years ago

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

Apr 1, 2024, 4:15 PM EDT - 2 years ago

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

NeurAxis Announces Highmark BCBS Policy Coverage

Mar 11, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces Highmark BCBS Policy Coverage

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

Mar 4, 2024, 9:00 AM EST - 2 years ago

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Feb 27, 2024, 11:00 AM EST - 2 years ago

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Jan 31, 2024, 9:00 AM EST - 2 years ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Dec 20, 2023, 9:00 AM EST - 2 years ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

NeurAxis Reports Third Quarter 2023 Financial Results

Nov 20, 2023, 5:30 PM EST - 2 years ago

NeurAxis Reports Third Quarter 2023 Financial Results

NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 15, 2023, 9:00 AM EST - 2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

NeurAxis Secures $3 Million Financing

Nov 14, 2023, 9:00 AM EST - 2 years ago

NeurAxis Secures $3 Million Financing

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Nov 8, 2023, 9:00 AM EST - 2 years ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

NeurAxis Reports Second Quarter 2023 Financial Results

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2023 Financial Results

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

Sep 13, 2023, 9:00 AM EDT - 2 years ago

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Sep 12, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 29, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

NeurAxis Highlights Strength of its Board of Directors

Aug 24, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Strength of its Board of Directors

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

Aug 22, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

Aug 17, 2023, 9:02 AM EDT - 2 years ago

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

stockinvestor102
stockinvestor102 Mar. 12 at 5:09 PM
Bought shares of $NRXS
1 · Reply
Andyc545
Andyc545 Mar. 11 at 2:48 AM
$NRXS ATH!! and this board is quiet...
1 · Reply
S144
S144 Mar. 10 at 6:17 PM
$NRXS +11% today ! @alexpitti
1 · Reply
trading_momentum_x
trading_momentum_x Mar. 10 at 10:59 AM
$NRXS back on watch after its cup and handle breakout now potentially flagging on smaller timeframes. Has decent support near 5.55 with multiple touches and good buy volume Todays hammer candle suggest buyers are still interested here. Would take entry on recapture of 5dema for a change of direction.
0 · Reply
wallstpirate
wallstpirate Mar. 2 at 5:11 PM
$NRXS Amazing video https://microcapclub.com/neuraxis-nrxs-growth-stage-medtech/
0 · Reply
S144
S144 Mar. 2 at 3:37 PM
$NRXS NeurAxis (NRXS): Growth-Stage Medtech: https://microcapclub.com/neuraxis-nrxs-growth-stage-medtech Interview with CEO: https://www.youtube.com/watch?v=HTd_XbwODF4 @alexpitti
1 · Reply
Tennis_4567
Tennis_4567 Mar. 2 at 1:11 PM
$NRXS https://youtu.be/HTd_XbwODF4?si=-niYpsR07tbu0m2k
0 · Reply
S144
S144 Mar. 2 at 7:27 AM
$NRXS Subscribe to Microcap Opportunities at substack. They have the best info about the stock. The latest article: Our Flagship Stock NeurAxis (NRXS) is Sailing Fast... and Just Getting Started! https://microcapopportunities.substack.com/p/our-flagship-stock-neuraxis-nrxs
0 · Reply
trading_momentum_x
trading_momentum_x Mar. 1 at 3:35 AM
$NRXS cup and handle still fully playing out and now in a former supply zone near 6$ Potential is here is 6.70 area and then on to all time high levels. Tons of buy volume forming in current range and very bullish as long as price holds 5.66 area
0 · Reply
S144
S144 Feb. 26 at 7:46 PM
$NRXS $5.7 ! It will be $6 very soon.
0 · Reply
Bobinato
Bobinato Feb. 18 at 3:39 PM
$NRXS no volume but by god it's beautiful
1 · Reply
trading_momentum_x
trading_momentum_x Feb. 15 at 4:38 AM
$NRXS has been a slow and steady gainer and its cup and handle justifies its movement. Could easily see 6$ or more here
0 · Reply
trading_momentum_x
trading_momentum_x Feb. 15 at 3:29 AM
$NRXS on watch still for its cup and handle play. We’ve seen a breakout above the neckline and a pullback and now another leg up. The cup and handle Vpa gives this an estimated target near 6$, near its last major breakout resistance
0 · Reply
allisonmarie
allisonmarie Feb. 12 at 3:03 PM
$NRXS Big Short Squeeze beginning. Up 10% now. Need volume for a huge pop...
0 · Reply
allisonmarie
allisonmarie Feb. 12 at 2:52 PM
$NRXS Short squeeze now..... Once this breaks $5.00, off to the races.
0 · Reply
Tennis_4567
Tennis_4567 Feb. 10 at 9:00 PM
$NRXS
0 · Reply
allisonmarie
allisonmarie Feb. 10 at 8:02 PM
$NRXS is set up for an explosive short squeeze if we can get volume behind it......
0 · Reply
allisonmarie
allisonmarie Feb. 10 at 7:42 PM
Short squeeze setting up on $NRXS
0 · Reply
VolumeCore
VolumeCore Feb. 9 at 2:07 PM
$NRXS Pharmacy or healthcare IT; operates in a complex, regulated reimbursement environment.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 6 at 10:00 AM
$NRXS Current Stock Price: $4.35
0 · Reply
biggercapital
biggercapital Feb. 4 at 12:37 AM
Our $NRXS filing https://www.sec.gov/Archives/edgar/data/1288478/000092189526000208/xslSCHEDULE_13G_X01/primary_doc.xml
1 · Reply
AshenBlade
AshenBlade Feb. 1 at 10:43 PM
$NRXS Liquidity pressure raises questions about how long the company can operate without additional financing..
1 · Reply